Now showing items 1-1 of 1
Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms
(C M B Assoc, 2018)
Chronic myeloid leukemia (CML) is a hematopoietic malignancy characterized by the t(9; 22) and the related oncogene, BCR-ABL. Tyrosine kinase activity of fusion protein BCR-ABL is the main cause of CML. Even if imatinib ...